Truist analyst Lucas Servera raised the firm’s price target on RXO Inc. (RXO) to $26 from $20 and keeps a Buy rating on the shares. The company’s Q1 results reinforced the firm’s view that RXO is entering the early stages of a cyclical earnings recovery as spot mix, GP/load, contract pricing, and sequential volume trends all improved materially through the quarter, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target raised to $22 from $15 at Stifel
- RXO Inc. price target raised to $24 from $17 at Citi
- RXO Inc. price target raised to $20 from $17 at Barclays
- RXO Inc. price target raised to $22 from $15 at Wells Fargo
- Ken Hoexter Lifts RXO Price Target to $25 on AI-Driven Gains but Maintains Hold Amid Balanced Risk-Reward